VAN ANDEL RESEARCH INSTITUTE: Form 990, tax year 2009
View the entire original 990 at ProPublica ↗
- Organization
- VAN ANDEL RESEARCH INSTITUTE (EIN 52-2000823)
- Tax period
- 2009-12-01 to 2010-11-30
- Filed
- 2011-10-14
- IRS object ID
- 201142879349301119
- Schema version
- 2009v1.7
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule K
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2011-10-14T13:03:09-05:00 | Timestamp |
| Tax Period End Date | 2010-11-30 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Deloitte Tax LLP | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 200 Renaissance Center STE 3900 | AddressLine1 |
| City | Detroit | City |
| State | MI | State |
| ZIP Code | 48243 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2009-12-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522000823 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | VAN ANDEL RESEARCH INSTITUTE | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | VANA | NameControl |
| Phone | 6162345000 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 333 BOSTWICK Avenue NE | AddressLine1 |
| City | GRAND RAPIDS | City |
| State | MI | State |
| ZIP Code | 49503 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | Timothy Myers | Name |
| Title | CFO | Title |
| Phone | 6162345368 | Phone |
| Date Signed | 2011-10-14 | DateSigned |
| Authorize Third Party | 1 | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 3133963000 | Phone |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2009 | TaxYear |
| Build TS | 2016-03-07 17:11:31Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | TIMOTHY J MYERS | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 333 BOSTWICK Avenue NE | AddressLine1 |
| City | GRAND RAPIDS | City |
| State | MI | State |
| ZIP Code | 49503 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 79263260 | GrossReceipts |
| Group Return For Affiliates | 0 | GroupReturnForAffiliates |
| Organization501c | X | Organization501c |
| Web Site | WWW.VAI.ORG | WebSite |
| Type Of Organization Trust | X | TypeOfOrganizationTrust |
| Year Formation | 1996 | YearFormation |
| State Legal Domicile | MI | StateLegalDomicile |
| Activity Or Mission Description | Medical Research Organization | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 6 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 3 | NbrIndependentVotingMembers |
| Total Nbr Employees | 248 | TotalNbrEmployees |
| Total Nbr Volunteers | 0 | TotalNbrVolunteers |
| Total Gross UBI | 839181 | TotalGrossUBI |
| Net Unrelated Business Txbl Income | 181235 | NetUnrelatedBusinessTxblIncome |
| Contributions Grants Prior Year | 43991473 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 69868505 | ContributionsGrantsCurrentYear |
| Program Service Revenue Prior Year | 1854145 | ProgramServiceRevenuePriorYear |
| Program Service Revenue CY | 1332729 | ProgramServiceRevenueCY |
| Investment Income Prior Year | 626862 | InvestmentIncomePriorYear |
| Investment Income Current Year | -272304 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | 4460793 | OtherRevenuePriorYear |
| Other Revenue Current Year | 5766282 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 50933273 | TotalRevenuePriorYear |
| Total Revenue Current Year | 76695212 | TotalRevenueCurrentYear |
| Grants And Similar Amnts CY | 221029 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 18873211 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 22508665 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp CY | 0 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 407930 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 30800458 | OtherExpensePriorYear |
| Other Expenses Current Year | 69776826 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 49673669 | TotalExpensesPriorYear |
| Total Expenses Current Year | 92506520 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | 1259604 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | -15811308 | RevenuesLessExpensesCY |
| Total Assets BOY | 250543499 | TotalAssetsBOY |
| Total Assets EOY | 253776425 | TotalAssetsEOY |
| Total Liabilities BOY | 287653664 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 312690617 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | -37110165 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | -58914192 | NetAssetsOrFundBalancesEOY |
| Mission Description | Medical Research Organization | MissionDescription |
| Significant New Program Services | 0 | SignificantNewProgramServices |
| Significant Change | 0 | SignificantChange |
| Expense | 2105245 | Expense |
| Description | The laboratory of structural sciences is focused on studying the structures and functions of protein/ligand complexes that play key roles in major hormone signaling pathways. See schedule O for further information about this program. | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 1394369 | Expense |
| Description | The laboratory of Molecular Oncology has focused on understanding the numerous and diverse roles that MET plays in malignant progression and metastasis. Schedule O provides further information regarding this program's accomplishment. | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 929297 | Expense |
| Description | The laboratory of cancer and developmental cell biology is focused on understanding anthrax lethal factor, as well as working with the Canine Hereditary Cancer Consortium to study cancer within canines to discover the genomic causes of disease in both canines and people. Schedule O provides further information regarding this program's accomplishments. | Description |
Activity Other ActivityOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 68273236 | Expense |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Other Program Service Exp | 68273236 | TotalOfOtherProgramServiceExp |
| Total Program Service Expense | 72702147 | TotalProgramServiceExpense |
| Described In501 C3 | 1 | DescribedIn501C3 |
| Schedule B Required | 1 | ScheduleBRequired |
| Political Activities | 0 | PoliticalActivities |
| Lobbying Activities | 1 | LobbyingActivities |
| Donor Advised Funds | 0 | DonorAdvisedFunds |
| Conservation Easements | 0 | ConservationEasements |
| Collections Of Art | 1 | CollectionsOfArt |
| Credit Counseling | 0 | CreditCounseling |
| Term Or Permanent Endowments | 0 | TermOrPermanentEndowments |
| Balance Sheet Amounts Reported | 1 | BalanceSheetAmountsReported |
| Independent Audit Financial Stmt | 0 | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | 1 | ConsolidatedAuditFinancialStmt |
| School | 0 | School |
| Foreign Office | 0 | ForeignOffice |
| Foreign Activities | 1 | ForeignActivities |
| More Than5000 K To Organizations | 0 | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividuals |
| Professional Fundraising | 0 | ProfessionalFundraising |
| Fundraising Activities | 0 | FundraisingActivities |
| Gaming | 0 | Gaming |
| Hospital | 0 | Hospital |
| Grants To Organizations | 1 | GrantsToOrganizations |
| Grants To Individuals | 1 | GrantsToIndividuals |
| Schedule J Required | 1 | ScheduleJRequired |
| Tax Exempt Bonds | 1 | TaxExemptBonds |
| Invest Tax Exempt Bonds | 0 | InvestTaxExemptBonds |
| Escrow Account | 0 | EscrowAccount |
| On Behalf Of Issuer | 0 | OnBehalfOfIssuer |
| Excess Benefit Transaction | 0 | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | 0 | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | 0 | LoanToOfficerOrDQP |
| Grant To Related Person | 0 | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | 1 | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | 0 | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | 0 | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | 0 | DeductibleNonCashContributions |
| Deductible Contributions Of Art | 0 | DeductibleContributionsOfArt |
| Terminated | 0 | Terminated |
| Partial Liquidation | 0 | PartialLiquidation |
| Disregarded Entity | 1 | DisregardedEntity |
| Related Entity | 1 | RelatedEntity |
| Related Org Controlled Entity | 1 | RelatedOrgControlledEntity |
| Transfers To Exempt Non Chrtbl Org | 0 | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | 0 | ActivitiesConductedPartnership |
| Schedule O Required | 1 | ScheduleORequired |
| Number Forms Transmitted With1096 | 108 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 0 | NumberW2GIncluded |
| Number Of Employees | 248 | NumberOfEmployees |
| Employment Tax Returns Filed | 1 | EmploymentTaxReturnsFiled |
| Unrelated Business Income | 1 | UnrelatedBusinessIncome |
| Form990-T Filed | 1 | Form990-TFiled |
| Foreign Financial Account | 0 | ForeignFinancialAccount |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTrans |
| Taxable Party Notification | 0 | TaxablePartyNotification |
| Non Deductible Contributions | 0 | NonDeductibleContributions |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributions |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOf |
| Funds To Pay Premiums | 0 | FundsToPayPremiums |
| Premiums Paid | 0 | PremiumsPaid |
| Nbr Voting Governing Body Members | 6 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 3 | NumberIndependentVotingMembers |
| Family Or Business Relationship | 0 | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | 1 | DelegationOfManagementDuties |
| Changes To Organizing Docs | 1 | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuse |
| Members Or Stockholders | 0 | MembersOrStockholders |
| Election Of Board Members | 1 | ElectionOfBoardMembers |
| Decisions Subject To Approval | 0 | DecisionsSubjectToApproval |
| Minutes Of Governing Body | 1 | MinutesOfGoverningBody |
| Minutes Of Committees | 1 | MinutesOfCommittees |
| Officer Mailing Address | 0 | OfficerMailingAddress |
| Local Chapters | 0 | LocalChapters |
| Form990 Provided To Governing Body | 1 | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | 1 | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | 1 | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | 1 | RegularMonitoringEnforcement |
| Whistleblower Policy | 1 | WhistleblowerPolicy |
| Document Retention Policy | 1 | DocumentRetentionPolicy |
| Compensation Process CEO | 1 | CompensationProcessCEO |
| Compensation Process Other | 1 | CompensationProcessOther |
| Investment In Joint Venture | 0 | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | MI | StatesWhereCopyOfReturnIsFiled |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
Name Business NameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TIMOTHY J MYERS | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Telephone Number | 6162345368 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 333 BOSTWICK Avenue NE | AddressLine1 |
| City | GRAND RAPIDS | City |
| State | MI | State |
| ZIP Code | 495032518 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionA (18 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | OfficerOfficer | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | Key EmployeeKeyEmployee | Highest Compensated EmployeeHighestCompensatedEmployee |
|---|---|---|---|---|---|---|---|---|
| DAVID VAN ANDEL | ||||||||
| Chairman / CEO | 40.00 | X | X | 414308 | 0 | 39326 | ||
| GEORGE VANDE WOUDE | ||||||||
| DIST Investigator | 40.00 | X | 320002 | 0 | 41487 | X | ||
| Dr James Fahner | ||||||||
| TRUSTEE | 1.00 | X | 15000 | 0 | 0 | |||
| Dr FRITZ ROTTMAN PHD | ||||||||
| TRUSTEE | 1.00 | X | 11000 | 4000 | 0 | |||
| DR JEFFREY TRENT | ||||||||
| PRESIDENT & RESEARCH DIRECTOR | 40.00 | X | X | 0 | 87170 | 1463 | ||
| JOSE CARDENAS | ||||||||
| TRUSTEE | 1.00 | X | 0 | 0 | 0 | |||
| R JACK FRICK | ||||||||
| CHIEF ADMINISTRATIVE OFFICER | 40.00 | X | 269728 | 0 | 49762 | |||
| STEVE HEACOCK | ||||||||
| CAO / GENERAL COUNSEL | 40.00 | X | 314433 | 0 | 49362 | |||
| Joseph Gavan | ||||||||
| VP-Communications & Development | 40.00 | X | 187611 | 0 | 32112 | |||
| TIMOTHY MYERS | ||||||||
| CHIEF FINANCIAL OFFICER | 40.00 | X | 137189 | 0 | 18371 | |||
| LINDA ZARZECKI | ||||||||
| VICE PRESIDENT OF HUMAN RESOURCES | 40.00 | X | 143913 | 0 | 18841 | |||
| JEFFREY BATTERSHALL | ||||||||
| SECRETARY | 1.00 | X | 0 | 0 | 0 | |||
| KATHleen VOGELSANG | ||||||||
| Dir of Investments | 40.00 | 251394 | 0 | 20221 | X | |||
| Ted Heilman | ||||||||
| SR Portfolio Manager | 40.00 | 211555 | 0 | 19424 | X | |||
| Dr H Eric Xu | ||||||||
| DIst Investigator | 40.00 | 199344 | 0 | 22373 | X | |||
| Dr James Resau | ||||||||
| Dist Investigator | 40.00 | 181995 | 0 | 22258 | X | |||
| JOHN BENDER | ||||||||
| CLINICAL OPERATIONS DIRECTOR | 40.00 | 0 | 0 | 0 | X | |||
| BRYON CAMPBELL | ||||||||
| CHIEF INFORMATION OFFICER | 40.00 | 179709 | 0 | 21433 | X | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 2837181 | TotalReportableCompFromOrg |
| Total Reportable Comp Frm Rltd Orgs | 91170 | TotalReportableCompFrmRltdOrgs |
| Total Other Compensation | 356433 | TotalOtherCompensation |
| Number Individuals GT100 K | 30 | NumberIndividualsGT100K |
| Formers Listed | 0 | FormersListed |
| Total Comp GT150 K | 1 | TotalCompGT150K |
| Compensation From Other Sources | 0 | CompensationFromOtherSources |
Contractor Compensation ContractorCompensation (5 entries)
| Address Line1AddressOfContractor/AddressUS/AddressLine1 | CityAddressOfContractor/AddressUS/City | StateAddressOfContractor/AddressUS/State | ZIP CodeAddressOfContractor/AddressUS/ZIPCode | Description Of ServicesDescriptionOfServices | CompensationCompensation |
|---|---|---|---|---|---|
| HUNT - OWEN AMES & KIMBALL (See Schedule | |||||
| 6720 SCOTTSDALE DR STE 300 | SCOTTSDALE | AZ | 85253 | CONSTRUCTION SERVICES | 32089485 |
| Bank of AmericaMerrill Lynch | |||||
| 100 N Tryon St | Charlotte | NC | 28263 | Credit Enhancement Fees | 1135277 |
| rafael vinoly pc | |||||
| 50 van dam street | new york | NY | 10013 | architecture/ design | 683534 |
| translational genomics institute | |||||
| 445 n fifth st suite 600 | phoenix | AZ | 85004 | contract labor | 560936 |
| warner norcross & judd | |||||
| 111 lyon st 900 old kent | grand rapids | MI | 495032487 | legal/ consulting | 500800 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number Of Contractors GT100 K | 24 | NumberOfContractorsGT100K |
| Related Organizations | 63319977 | RelatedOrganizations |
| Government Grants | 5652752 | GovernmentGrants |
| All Other Contributions | 895776 | AllOtherContributions |
| Total Contributions | 69868505 | TotalContributions |
Program Service Revenue ProgramServiceRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description | Research billed rev | Description |
| Business Code | 541700 | BusinessCode |
| Total Revenue Column | 1332729 | TotalRevenueColumn |
| Related Or Exempt Function Income | 504558 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 828171 | UnrelatedBusinessRevenue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | 1332729 | TotalProgramServiceRevenue |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 202696 | TotalRevenueColumn |
| Exclusion | $202,696 | ExclusionAmount |
Income From Invest Bond Proceeds IncomeFromInvestBondProceeds
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 24016 | TotalRevenueColumn |
| Exclusion | $24,016 | ExclusionAmount |
Royalties Revenue RoyaltiesRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 319808 | TotalRevenueColumn |
| Exclusion | $319,808 | ExclusionAmount |
Gross Rents GrossRents
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | 2019921 | Real |
| Personal | 15165 | Personal |
Less Rental Expenses LessRentalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | 1053328 | Real |
| Personal | 5655 | Personal |
Rental Income Or Loss RentalIncomeOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | 966593 | Real |
| Personal | 9510 | Personal |
Net Rental Income Or Loss NetRentalIncomeOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 976103 | TotalRevenueColumn |
| Related Or Exempt Function Income | 965093 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 11010 | UnrelatedBusinessRevenue |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | 1010049 | Other |
Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | 1509065 | Other |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | -499016 | Other |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -499016 | TotalRevenueColumn |
| Related Or Exempt Function Income | -499016 | RelatedOrExemptFunctionIncome |
Other Revenue Misc OtherRevenueMisc (3 entries)
| DescriptionDescription | Business CodeBusinessCode | Total Revenue ColumnTotalRevenueColumn | Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome | ExclusionExclusionAmount |
|---|---|---|---|---|
| Rel. Party Admin Suppo | 561000 | 3858580 | 3858580 | |
| Gain on Joint Ventures | 523000 | 827697 | 827697 | |
| Reimbursed Expenses | 900099 | 154548 | $154,548 |
Miscellaneous Revenue MiscellaneousRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -370454 | TotalRevenueColumn |
| Related Or Exempt Function Income | -432354 | RelatedOrExemptFunctionIncome |
| Exclusion | $61,900 | ExclusionAmount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Revenue | 4470371 | TotalOtherRevenue |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 76695212 | TotalRevenueColumn |
| Related Or Exempt Function Income | 5224558 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 839181 | UnrelatedBusinessRevenue |
| Exclusion | $762,968 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 221029 | Total |
| Program Services | 221029 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3622793 | Total |
| Program Services | 1329366 | ProgramServices |
| Management And General | 2293427 | ManagementAndGeneral |
Other Salaries And Wages OtherSalariesAndWages
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 14603433 | Total |
| Program Services | 8675344 | ProgramServices |
| Management And General | 5673361 | ManagementAndGeneral |
| Fundraising | 254728 | Fundraising |
Pension Plan Contributions PensionPlanContributions
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1093027 | Total |
| Program Services | 670914 | ProgramServices |
| Management And General | 407337 | ManagementAndGeneral |
| Fundraising | 14776 | Fundraising |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2049319 | Total |
| Program Services | 1258578 | ProgramServices |
| Management And General | 762372 | ManagementAndGeneral |
| Fundraising | 28369 | Fundraising |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1140093 | Total |
| Program Services | 700361 | ProgramServices |
| Management And General | 423774 | ManagementAndGeneral |
| Fundraising | 15958 | Fundraising |
Fees For Services Legal FeesForServicesLegal
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1050515 | Total |
| Program Services | 66018 | ProgramServices |
| Management And General | 984497 | ManagementAndGeneral |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 150165 | Total |
| Management And General | 150165 | ManagementAndGeneral |
Fees For Services Lobbying FeesForServicesLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 112499 | Total |
| Management And General | 112499 | ManagementAndGeneral |
Fees For Services Other FeesForServicesOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2207131 | Total |
| Program Services | 1372375 | ProgramServices |
| Management And General | 834756 | ManagementAndGeneral |
Advertising Advertising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 619288 | Total |
| Program Services | 59022 | ProgramServices |
| Management And General | 560266 | ManagementAndGeneral |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 147402 | Total |
| Program Services | 76802 | ProgramServices |
| Management And General | 70600 | ManagementAndGeneral |
Information Technology InformationTechnology
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 408781 | Total |
| Program Services | 155053 | ProgramServices |
| Management And General | 253728 | ManagementAndGeneral |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2521237 | Total |
| Program Services | 2044462 | ProgramServices |
| Management And General | 476775 | ManagementAndGeneral |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 756248 | Total |
| Program Services | 594240 | ProgramServices |
| Management And General | 162008 | ManagementAndGeneral |
Conferences Meetings ConferencesMeetings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 127649 | Total |
| Program Services | 92028 | ProgramServices |
| Management And General | 35621 | ManagementAndGeneral |
Interest Interest
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 13165289 | Total |
| Program Services | 10509819 | ProgramServices |
| Management And General | 2655470 | ManagementAndGeneral |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 8753752 | Total |
| Program Services | 7318541 | ProgramServices |
| Management And General | 1435211 | ManagementAndGeneral |
Insurance Insurance
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 400688 | Total |
| Program Services | 188774 | ProgramServices |
| Management And General | 211914 | ManagementAndGeneral |
Other Expenses OtherExpenses (5 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral |
|---|---|---|---|
| TGEN CONTRIBUTION PAYAB | 29228120 | 29228120 | |
| Lab Supplies & Services | 3117006 | 3101120 | 15886 |
| EQUIPMENT & SOFTWARE | 1703707 | 997274 | 706433 |
| TGEN INTEGRATION | 1245773 | 1245773 | |
| MSU DISCOUNT ON PAYABLE | 1000746 | 1000746 |
All Other Expenses AllOtherExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3060830 | Total |
| Program Services | 1796388 | ProgramServices |
| Management And General | 1170343 | ManagementAndGeneral |
| Fundraising | 94099 | Fundraising |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 92506520 | Total |
| Program Services | 72702147 | ProgramServices |
| Management And General | 19396443 | ManagementAndGeneral |
| Fundraising | 407930 | Fundraising |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 14724976 | BOY |
| EOY | 6671503 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1392801 | BOY |
| EOY | 2623400 | EOY |
Accounts Receivable AccountsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2589305 | BOY |
| EOY | 1236706 | EOY |
Other Notes Loans Receivable Net OtherNotesLoansReceivableNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1492741 | BOY |
| EOY | 2351000 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 842304 | BOY |
| EOY | 823236 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 264311645 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 44532823 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 201916499 | BOY |
| EOY | 219778822 | EOY |
Investments Other Securities InvestmentsOtherSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 16821154 | BOY |
| EOY | 1887951 | EOY |
Investments Program Related InvestmentsProgramRelated
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 97917 | BOY |
| EOY | 97917 | EOY |
Other Assets Total OtherAssetsTotal
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 10665802 | BOY |
| EOY | 18305890 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 250543499 | BOY |
| EOY | 253776425 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 25230783 | BOY |
| EOY | 25465798 | EOY |
Deferred Revenue DeferredRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 977793 | BOY |
| EOY | 1453448 | EOY |
Tax Exempt Bond Liabilities TaxExemptBondLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 220000000 | BOY |
| EOY | 220000000 | EOY |
Mort Notes Pybl Secured Invest Prop MortNotesPyblSecuredInvestProp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 385000 | BOY |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 41060088 | BOY |
| EOY | 65771371 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 287653664 | BOY |
| EOY | 312690617 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | -37614343 | BOY |
| EOY | -39862048 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 503178 | BOY |
| EOY | -19053644 | EOY |
Permanently Restricted Net Assets PermanentlyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1000 | BOY |
| EOY | 1500 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | -37110165 | BOY |
| EOY | -58914192 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 250543499 | BOY |
| EOY | 253776425 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | 0 | AccountantCompileOrReview |
| FS Audited | 1 | FSAudited |
| Audit Committee | 1 | AuditCommittee |
| Financial Statement Consolidated | X | FinancialStatementConsolidated |
| Federal Grant Audit Required | 1 | FederalGrantAuditRequired |
| Federal Grant Audit Performed | 1 | FederalGrantAuditPerformed |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Org170b1 Aiii | X | MedicalResearchOrg170b1Aiii |
Hospital Name And Address HospitalNameAndAddress
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SPECTRUM HEALTH | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| City | GRAND RAPIDS | City |
| State | MI | State |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Amt Of4955 Tax | 0 | AmtOf4955Tax |
| Amt Of4955 Tax On Managers | 0 | AmtOf4955TaxOnManagers |
| Volunteers | 0 | Volunteers |
| Paid Staff Or Management | 1 | PaidStaffOrManagement |
| Media Advertisements | 0 | MediaAdvertisements |
| Mailings Members | 0 | MailingsMembers |
| Publications Or Broadcast | 0 | PublicationsOrBroadcast |
| Grants Other Organizations | 0 | GrantsOtherOrganizations |
| Direct Contact Legislators | 1 | DirectContactLegislators |
| Direct Contact Legislators | $84,375 | DirectContactLegislatorsAmount |
| Rallies Demonstrations | 0 | RalliesDemonstrations |
| Other Activities | 1 | OtherActivities |
| Other Activities | $28,124 | OtherActivitiesAmount |
| Total Lobbying Expenditures IIB | 112499 | TotalLobbyingExpendituresIIB |
| Not Described In501c3 | 0 | NotDescribedIn501c3 |
Form990 Schedule C Part IV Form990ScheduleCPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | Part II-B, Line 1i: | Identifier |
| Return Reference | Explanation of Other Lobbying Activities: | ReturnReference |
| Explanation | John Van Fossen / Clark Hill: State of Michigan: MET WITH MICHIGAN ECONOMIC DEVELOPMENT CORPORATION, OFFICE OF GOVERNOR GRANHOLM, OFFICE OF LT. GOVERNOR JOHN CHERRY, MICHIGAN STATE SENATE and HOUSE OF REPRESENTATIVEs, AND ATTORNEY GENERAL OF MICHIGAN - LIFE SCIENCE PROGRAMS AND FUNDING; MICHIGAN DEPARTMENT OF COMMUNITY HEALTH RESEARCH AND HEALTH CARE SUPPORT PROGRAMS FEDERAL GOVERNMENT: FUNDING FOR NCI/ NIH; AND STEM EDUCATION PROGRAMS | Explanation |
Schedule D IRS990ScheduleD
Art Public Exhibition Amts ArtPublicExhibitionAmts
| Field | Value | IRS element (for citing) |
|---|---|---|
| Assets In Part X | 435037 | AssetsInPartX |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Collect Used For Public Exhibition | X | CollectUsedForPublicExhibition |
| Solicited Assets For Sale | 0 | SolicitedAssetsForSale |
| Endowments Held By Related Orgs | 1 | EndowmentsHeldByRelatedOrgs |
| Are Related Orgs Listed Schedule R | 1 | AreRelatedOrgsListedScheduleR |
Buildings Buildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 218579630 | OtherCostOrOtherBasis |
| Depreciation | 20716931 | Depreciation |
| Book Value | 197862699 | BookValue |
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 38634573 | OtherCostOrOtherBasis |
| Depreciation | 23793217 | Depreciation |
| Book Value | 14841356 | BookValue |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 7097442 | OtherCostOrOtherBasis |
| Depreciation | 22675 | Depreciation |
| Book Value | 7074767 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 219778822 | TotalOfBookValueLandBuildings |
Other Assets OtherAssets (2 entries)
| DescriptionDescription | Book ValueBookValue |
|---|---|
| BOND ISSUANCE COSTS NET OF ACCUMULATED AMORTIZATION | 1615890 |
| Pledged Securities | 16690000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | 18305890 | TotalBookValueOtherAssets |
Other Liabilities OtherLiabilities (5 entries)
| DescriptionDescription | AmountAmount |
|---|---|
| ACCRUED POSTRETIREMENT BENEFIT OBLIGATION | $1,065,477 |
| Unrealized Loss on Bond Swap | $36,022,174 |
| MSU Med School - Contribution Payable | $9,364,776 |
| Capital Lease | $90,824 |
| TGEN - CONTRIBUTION PAYABLE | $19,228,120 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Amounts | 65771371 | TotalOfAmounts |
| Total Revenue | 76695212 | TotalRevenue |
| Total Expenses | 92506520 | TotalExpenses |
| Excess Or Deficit For Year | -15811308 | ExcessOrDeficitForYear |
| Net Unrealized GL On Investments | 227235 | NetUnrealizedGLOnInvestments |
| Other | -$6,219,955 | OtherAmount |
| Total Adjustments | -5992720 | TotalAdjustments |
| Excess Or Deficit Per FS | -21804028 | ExcessOrDeficitPerFS |
| Tot Revenue Etc Audited Fincl Stmt | 73039851 | TotRevenueEtcAuditedFinclStmt |
| Net Unrealized Gains Investments | 227235 | NetUnrealizedGainsInvestments |
| Revenue Not Rptd F990 | 227235 | RevenueNotRptdF990 |
| Revenue Subtotal | 72812616 | RevenueSubtotal |
| Other Revenues Not Included | 3882596 | OtherRevenuesNotIncluded |
| Revenue Not Rptd On Fin Stmt | 3882596 | RevenueNotRptdOnFinStmt |
| Total Revenue Per Form990 | 76695212 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 94843878 | TotExpensesEtcAuditedFinclStmt |
| Other Expenses Included | 6219955 | OtherExpensesIncluded |
| Expenses Not Rptd F990 | 6219955 | ExpensesNotRptdF990 |
| Expenses Subtotal | 88623923 | ExpensesSubtotal |
| Other Expenses Not Included | 3882596 | OtherExpensesNotIncluded |
| Expenses Not Rptd On Fin Stmt | 3882596 | ExpensesNotRptdOnFinStmt |
| Total Expenses Per Form990 | 92506519 | TotalExpensesPerForm990 |
Form990 Schedule D Part XIV Form990ScheduleDPartXIV (7 entries)
| IdentifierIdentifier | ExplanationExplanation | Return ReferenceReturnReference |
|---|---|---|
| Part III, Line 4: | The glass Chihuly sculpture is a unique, one-of-a-kind Chandelier reminiscent of the DNA double helix. The Chandelier, which is placed in the reception area, provides motivation and inspiration as Scientists are driven to understand the genetic basis of diseases in their pursuit of cures and other therapies. | |
| Part V, Line 4: | TO SUPPORT THE CORE RESEARCH OF VARI BY SUPPLYING A STEADY SOURCE OF INCOME FOR ITS OPERATING BUDGETS. | Description of Intended Use of Endowment Funds: |
| PART VI, LINE 1B: THE INCREASE IN BUILDING BOOK VALUE REFLECTS THE 240,000 SQUARE FOOT PHASE II EXPANSION. THE PHASE II EXPANSION OF VARI NEARLY TRIPLED LABORATORY SPACE AND ALLOWS FOR CURRENT AND FUTURE GROWTH OF PROGRAMS AND EXPANDED RESEARCH SUCH AS NEURODEGENERATIVE DISEASES THROUGH THE JAY VAN ANDEL PARKINSONS RESEARCH LAB. | ||
| Part X: In June 2006, FASB issued ASC 740, Income Taxes (formerly FASB Interpretation (FIN) No. 48, Accounting for Uncertainty in Income Taxes - an interpretation of FASB Statement No. 109). ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting for interim periods, disclosure, and transition. ASC 740 is effective for fiscal years beginning after December 15, 2008. This standard was adopted for fiscal year ended November 30, 2010 and had no material impact on the consolidated financial statements. | ||
| Part XI, Line 8 and Part XIII Line 2d: NET LOSS RELATED TO THE INTEREST RATE SWAP. | ||
| Part XII and XIII, Line 4b: Expense reimbursements | ||
| Part V - All endowment funds are held at the Van Andel Institute (a related organization). |
Schedule F IRS990ScheduleF
Accts Actvs Out US Table AcctsActvsOutUSTable
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | East Asia & the Pacific | Region |
| Number Of Offices | 0 | NumberOfOffices |
| Number Of Employees | 0 | NumberOfEmployees |
| Type Of Activities Conducted | program services | TypeOfActivitiesConducted |
| Specific Services Provided | Research COllaboration - Legal Fees. | SpecificServicesProvided |
| Total Expenditures | 37768 | TotalExpenditures |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Number Of Offices | 0 | TotalNumberOfOffices |
| Total Number Of Employees | 0 | TotalNumberOfEmployees |
| Total Amount Spent | 37768 | TotalAmountSpent |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | 1 | RecordsMaintained |
Recipient Table RecipientTable
Recipient Name Business RecipientNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Friends of Crescent Park | BusinessNameLine1 |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 333 Bostwick Avenue NE | AddressLine1 |
| City | Grand Rapids | City |
| State | MI | State |
| ZIP Code | 49503 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN Of Recipient | 264562012 | EINOfRecipient |
| IRC Section | 501(c)3 | IRCSection |
| Amount Of Non Cash Assistance | 205579 | AmountOfNonCashAssistance |
| Purpose Of Grant | Support Crescent Park Renovation | PurposeOfGrant |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 1 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 0 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part III Form990ScheduleIPartIII (2 entries)
| Type Of GrantTypeOfGrant | Number Of RecipientsNumberOfRecipients | Amount Of Cash GrantAmountOfCashGrant |
|---|---|---|
| graduate student stipends for van andel graduate school and michigan state university students | 9 | 171062 |
| FOREIGN NATIONAL STUDENT STIPENDS | 16 | 67424 |
Form990 Schedule I Part IV Form990ScheduleIPartIV (2 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| Procedure for Monitoring Grants in the U.S.: | Part I, Line 2: | Schedule I, Part I, Line 2: VARI donated land improvements to the Friends of Crescent Park (FOCP), a 501(c)(3) organization dedicated to preserving, improving, expanding, and promoting Crescent Park, a city of Grand Rapids public park adjacent to VARI's facility. The board of trustees approved this donation via its annual budget approval process. |
| Other Information: | Part IV: | SCHEDULE I, PART I, LINE 2: FUNDS PROVIDED TO THE RESEARCH STUDENTS ARE CONTINUALLY MONITORED WHICH ENSURES THAT ALL FUNDS ARE MISSION-DRIVEN. STIPENDS ARE PROVIDED DIRECTLY TO THE STUDENTS FOR LIVING ASSISTANCE. THESE EXPENDITURES ARE MADE AT THE DISCRETION OF THE BOARD OF TRUSTEES. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | X | FirstClassOrCharterTravel |
| Housing Allowance Or Residence | X | HousingAllowanceOrResidence |
| Club Dues Or Fees | X | ClubDuesOrFees |
| Written Policy Re T And E Expenses | 0 | WrittenPolicyReTAndEExpenses |
| Substantiation Required | 1 | SubstantiationRequired |
| Compensation Committee | X | CompensationCommittee |
| Independent Consultant | X | IndependentConsultant |
| Written Employment Contract | X | WrittenEmploymentContract |
| Compensation Survey | X | CompensationSurvey |
| Board Or Committee Approval | X | BoardOrCommitteeApproval |
| Severance Payment | 1 | SeverancePayment |
| Supplemental Nonqual Retire Plan | 1 | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | 0 | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | 0 | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | 0 | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | 0 | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | 0 | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | 0 | AnyNonFixedPayments |
| Initial Contract Exception | 0 | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII (12 entries)
| Base Compensation Filing OrgBaseCompensationFilingOrg | Comp Based On Related OrgsCompBasedOnRelatedOrgs | Bonus Filing OrgBonusFilingOrg | Bonus Related OrgsBonusRelatedOrgs | Other Compensation Filing OrgOtherCompensationFilingOrg | Other Compensation Related OrgsOtherCompensationRelatedOrgs | Deferred Comp Filing OrgDeferredCompFilingOrg | Deferred Comp Related OrgsDeferredCompRelatedOrgs | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg | Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs | Total Compensation Filing OrgTotalCompensationFilingOrg | Total Compensation Related OrgsTotalCompensationRelatedOrgs | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg | Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DAVID VAN ANDEL | |||||||||||||
| 301378 | 0 | 92252 | 0 | 20678 | 0 | 38886 | 0 | 440 | 0 | 453634 | 0 | 0 | 0 |
| GEORGE VANDE WOUDE | |||||||||||||
| 301030 | 0 | 0 | 0 | 18972 | 0 | 40250 | 0 | 1237 | 0 | 361489 | 0 | 0 | 0 |
| R JACK FRICK | |||||||||||||
| 215921 | 0 | 52517 | 0 | 1290 | 0 | 40650 | 0 | 9112 | 0 | 319490 | 0 | 0 | 0 |
| STEVE HEACOCK | |||||||||||||
| 239709 | 0 | 57534 | 0 | 17190 | 0 | 40250 | 0 | 9112 | 0 | 363795 | 0 | 0 | 0 |
| Joseph Gavan | |||||||||||||
| 151611 | 0 | 35700 | 0 | 300 | 0 | 23000 | 0 | 9112 | 0 | 219723 | 0 | 0 | 0 |
| TIMOTHY MYERS | |||||||||||||
| 126473 | 0 | 10468 | 0 | 248 | 0 | 9259 | 0 | 9112 | 0 | 155560 | 0 | 0 | 0 |
| LINDA ZARZECKI | |||||||||||||
| 132576 | 0 | 10740 | 0 | 597 | 0 | 9729 | 0 | 9112 | 0 | 162754 | 0 | 0 | 0 |
| KATHleen VOGELSANG | |||||||||||||
| 158545 | 0 | 92399 | 0 | 450 | 0 | 11550 | 0 | 8671 | 0 | 271615 | 0 | 0 | 0 |
| Ted Heilman | |||||||||||||
| 142383 | 0 | 68744 | 0 | 428 | 0 | 10312 | 0 | 9112 | 0 | 230979 | 0 | 0 | 0 |
| Dr H Eric Xu | |||||||||||||
| 184051 | 0 | 14843 | 0 | 450 | 0 | 13262 | 0 | 9111 | 0 | 221717 | 0 | 0 | 0 |
| Dr James Resau | |||||||||||||
| 179837 | 0 | 178 | 0 | 1980 | 0 | 13147 | 0 | 9111 | 0 | 204253 | 0 | 0 | 0 |
| BRYON CAMPBELL | |||||||||||||
| 165103 | 0 | 13916 | 0 | 690 | 0 | 13262 | 0 | 9111 | 0 | 202082 | 0 | 0 | 0 |
Form990 Schedule J Part III Form990ScheduleJPartIII (4 entries)
| Return ReferenceReturnReference | ExplanationExplanation | IdentifierIdentifier |
|---|---|---|
| Part I, Line 1a | VARI allows for first-class or charter travel to officers and Trustees. Fitness center membership dues were paid by VARI for Steve Heacock totaling $500. There is not a policy for Housing allowance or residence for personal use. This is offered only on rare occasions and for special circumstances. Human Resources manages this on a case by case basis. | |
| Part I, Line 1b | A written policy is in place for first class/ charter travel and Health/ Social club dues/ fees. | |
| Part III | PART I, LINE 4A: SEVERANCE PAID TO STEVE HEACOCK TOTALED $448,871 IN FISCAL YEAR 2010, $0 CALENDAR YEAR 2009 PART I, LINE 4B: STEVE HEACOCK $5,077 FISCAL YEAR 2010,$16,500 CALENDAR YEAR 2009 GEORGE VANDE WOUDE $16,500 FISCAL YEAR 2010 AND CALENDAR YEAR 2009 | Supplemental Information |
| Part III | PART II: DR. JEFFREY TRENT WAS EMPLOYED BY THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (TGEN), A RELATED PARTY, DURING CALENDAR YEAR 2009. TGEN BECAME A RELATED PARTY TO VARI AS OF DECEMBER 1, 2009. ONE MONTH OF COMPENSATION IS THEREFORE REPORTED ON VARI'S FORM 990 PART VII AND SCHEDULE J PART II. | Supplemental Information |
Schedule K IRS990ScheduleK
Form990 Schedule K Part I Form990ScheduleKPartI
Issuer Name IssuerName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Michigan Strategic Fund Limited Obligation Revenue | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Issuer EIN | 521417332 | IssuerEIN |
| CUSIP Number | 594698EG3 | CUSIPNumber |
| Date Issued | 2008-04-10 | DateIssued |
| Issue Price | 220000000 | IssuePrice |
| Description Of Purpose | BUILD, EQUIP & FURNISH PHASE II RESEARCH FACILITY, & REFUND $50M PRIOR LTD | DescriptionOfPurpose |
| Defeased | 0 | Defeased |
| On Behalf Of Issuer | 0 | OnBehalfOfIssuer |
Form990 Schedule K Part II Form990ScheduleKPartII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Proceeds | 223159144 | TotalProceeds |
| Amount Defeased | 141613 | AmountDefeased |
| Amount Unspent | 3159144 | AmountUnspent |
| Issuance Costs From Proceeds | 1794232 | IssuanceCostsFromProceeds |
| Capital Expenditures | 112039949 | CapitalExpenditures |
| Year Of Subst Completion | 2009 | YearOfSubstCompletion |
| Current Refunding | 1 | CurrentRefunding |
| Advance Refunding | 0 | AdvanceRefunding |
| Final Allocation Made | 1 | FinalAllocationMade |
| Adequate Books And Recds Maintaind | 1 | AdequateBooksAndRecdsMaintaind |
Form990 Schedule K Part III Form990ScheduleKPartIII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Owning Bond Financed Property | 0 | OwningBondFinancedProperty |
| Any Lease Arrangements | 1 | AnyLeaseArrangements |
| Mngment Cntrct Bond Financd Prprty | 1 | MngmentCntrctBondFinancdPrprty |
| Any Research Agreements | 1 | AnyResearchAgreements |
| Bond Counsel Routinely Engaged | 1 | BondCounselRoutinelyEngaged |
| Prcntge Prvt Business Use By Others | 0.00000 | PrcntgePrvtBusinessUseByOthers |
| Percentage Of Prvt Business Re UBI | 0.00440 | PercentageOfPrvtBusinessReUBI |
| Total Private Business Use | 0.00440 | TotalPrivateBusinessUse |
| Post Issuance Compliance Procdrs | 1 | PostIssuanceComplianceProcdrs |
Form990 Schedule K Part IV Form990ScheduleKPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8038 T Filed | 1 | Form8038TFiled |
| Variable Rate Issue | 1 | VariableRateIssue |
| Hedge Identified In Books And Recds | 0 | HedgeIdentifiedInBooksAndRecds |
| Gross Proceeds Invested In GIC | 0 | GrossProceedsInvestedInGIC |
| Gross Proceeds Invested | 0 | GrossProceedsInvested |
| Exception To Rebate | 0 | ExceptionToRebate |
Schedule L IRS990ScheduleL
Form990 Schedule L Part IV Form990ScheduleLPartIV
Name Of Interested Person NameOfInterestedPerson
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Person | DR JEFFREY TRENT | NamePerson |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship | Officer | Relationship |
| Amount Of Transaction | 1235000 | AmountOfTransaction |
| Description Of Transaction | House Purchase | DescriptionOfTransaction |
| Sharing Of Revenues | 0 | SharingOfRevenues |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (15 entries)
| IdentifierIdentifier | ExplanationExplanation | Return ReferenceReturnReference |
|---|---|---|
| Form 990, Part VI, Section A, line 3 | Jerry Callahan, an Independent Contractor, serves as the Vice President of Business Development and Technology Transfer. | |
| Form 990, Part VI, Section A, line 4 | FORM 990, PART VI, SECTION A, LINE 4: THE VAN ANDEL RESEARCH INSTITUTE (VARI) AMENDED THEIR TRUST AGREEMENT TO GIVE AUTHORITY TO THE VAN ANDEL INSTITUTE BOARD OF DIRECTORS TO APPOINT AND REMOVE THE TRUSTEES OF VARI. | |
| Form 990, Part VI, Section A, line 7a | THE TRUSTEES OF VAN ANDEL INSTITUTE HAVE THE AUTHORITY TO ELECT ONE OR MORE MEMBERS OF THE GOVERNING BODY. | |
| Form 990, Part VI, Section B, line 11 | Following completion of the financial audit, the Form 990 is prepared and reviewed by management. It is then circulated to the full Board for review and final approval prior to filing with the IRS. | |
| Form 990, Part VI, Section B, line 12c | VARI has a written conflict of interest policy for which the organization enforced a process to identify, evaluate, and correct or remove potential conflicts of interest. The Van Andel Institute administers the conflict of interest (COI) policy through two committees: the Individual COI committee and the Institutional COI committee. The COI policy serves as guide for all staff members of the organization. The policy is intended to 1) provide staff with a useful resource when developing activities with outside industry and 2) provide assurance to staff that there is a committee to review and resolve potential conflicts of interest if / when they arise. The Individual COI committee, chaired by the Director of Compliance, generates an annual disclosure questionnaire distributed to all staff to enforce the policy. The conflicts committee is responsible for making recommendations to the Director. Resolutions are implemented with approval of the committee and in discussion with the VAI Chairman. The COI policy also serves as a guide for all members of the Board of Trustees and senior executives. The Institutional COI committee requires Trustees to complete an annual disclosure statement. This statement affirms their understanding of the policy, requires their acknowledgement of the organization's nonprofit status, and requests disclosure if / when potential conflicts arise. In the event a potential conflict arises at the Board or senior officer level, the Office of the General Counsel reviews and meets with the Board of Trustees to resolve potential conflicts. | |
| Form 990, Part VI, Section B, line 15 | Compensation for the CEO, Executive Management Officials, Executive Director, officers, and key employees is reviewed and approved annually by the independent compensation committee. The compensation committee is under the Van Andel Institute board of trustees, although all employees are employed by either Van Andel Research Institute or Van Andel Education Institute. Records and documentation, including comparability data, are kept and support decisions made on behalf of these arrangements and are contemporaneously documented. | |
| Form 990, Part VI, Section C, line 19 | These documents are available to the public upon request. | |
| Form 990, Part III, Lines 4a-4c | Line 4a - Program service activity #1 The laboratory of Structural Sciences is focused on studying the structures and functions of protein/ ligand complexes that play key roles in major hormone signaling pathways. The laboratory also works on exploring the structural information to develop therapeutic agents for treating human disease, including cancer and diabetes. Lab studies use multidisciplinary approaches, including molecular and cellular biology, biochemistry, animal physiology, and x-ray crystallography. Research in this group currently focuses on three areas: nuclear hormone receptors, the met tyrosine kinase receptor, and G protein-coupled receptors. These proteins, beyond their fundamental roles in biology, are important drug targets. In addition, this lab has extended their research to plant hormone abscisic acid (ABA) receptors. Recently they determined the structure of GR bound to deacylcortivazol (DAC), which binds to GR with 200-fold more potency than cortisol, the physiological glucocorticoid. The GR DAC structure reveals that the GR ligand binding pocket can be expanded dramatically, to twice its normal size. This new pocket provides a tremendous opportunity for drug design and screening. Using a computational screen, the lab identified several nonsteroidal ligands that like dissociated glucocorticoids in our cell-based assay. The lab is now running animal studies to confirm the physiological activities of these novel nonsteroidal ligands, which could lead to new methods of treating inflammation and autoimmune diseases. The lab has determined crystal structures of the ligand binding domain of the PTH and CRF receptors, and we are developing hormone analogs for treating osteoporosis, depression, and diabetes. Line 4b - Program service activity #2 Since discovering MET in 1984, and its ligand hepatocyte growth factor (HGF) in 1991, the laboratory of Molecular Oncology has focused on understanding the numerous and diverse roles that MET and HGF/SF plays in malignant progression and metastasis. Met is a transmembrane protein found in many different types of human cells. Increased expression of this protein has been found in most human solid tumors. The lab staff has developed antibodies against the Met protein that allow them to determine the location of cells that produce Met, and radiolabeled antibodies allow the imaging of tumors within living tissue. These antibodies have been shown to be valuable reagents for detecting cells that express Met. Studies are underway to determine for a variety of cancers the percentage that express the Met protein and to determine the feasibility of using Met expression or anti-Met antibodies as detection and prognostic tools for physicians. Recent lab achievements include the finding that MET may be an important target for an aggressive form of breast cancer, the development of important animal models for evaluating the efficacy of anti-HGF and/or anti-MET therapeutics, and the development of animal models for investigating the factors that modulate glioblastoma growth and evaluating therapeutic agents. Animal models are uniquely suited for evaluating new therapeutics, both alone and in combination with other therapeutics. Line 4c - Program service activity #3 The Laboratory of Cancer and Developmental Cell Biology is collaborating with various other physicians to try to exploit the properties of anthrax lethal factor and develop a new way to fight cancers such as melanoma, as well as to provide insight into the regulation of growth and vascularization of soft-tissue cancers called sarcomas. Recently the lab received funding to investigate the genetic causes of cancer including sarcomas in dogs. This lab has also been highly involved in rallying an unprecedented national alliance of veterinarians, basic scientists, and clinicians to form the Canine Hereditary Cancer Consortium (CHCC). The CHCC will integrate genomic studies of dogs with phenotypic and pharmacologic tests to predict therapies for human disease. This strategy leverages the low genetic diversity of pure bred dogs coupled with their predisposition for particular cancers to identify the underlying genetic lesions and biochemical pathways that contribute to these diseases, and then translate these discoveries to humans. Over the course of the last year, members of the CHCC have begun to define the fundamental goals that would characterize its growth with respect to cancer discovery in the coming decade. In the next two years the lab will focus our efforts on unraveling the genetic causes of several cancers, including but not limited to: hemangiosarcoma, osteosarcoma, melanoma, malignant histiocytic sarcoma, and lymphoma. The goals are ambitious but this is a one-time opportunity to make an incredible difference in the diagnosis and treatment of cancer in not only humans but also dogs. Line 4d - All other program service activities The Van Andel Research Institute (VARI) is dedicated to improving human health by determining the molecular basis of disease, utilizing genetics, bio-chemistry, structural and molecular biology, and chemistry. VARI's current focus is on building programs in basic sciences related to improving our understanding of cancer, including research programs in functional genomics, as well as, initial research efforts in neurological disorders, Parkinson's disease, and other devastating diseases. VARI has also made a long-term commitment to the development of programs that facilitate the translations of discoveries into therapeutic strategies for improving human health. VARI has over 30 program service accomplishments because of its varied reearch endeavors. In 2010, VARI researchers identified many disease related findings including potential ways to diagnose and treat several types of cancer. Researchers found a way to reverse resistance to sunitinib, a treatment that is currently the first line of defense against a form of kidney cancer. They also found a protein that may serve as a useful biomarker to predict patients' response to sunitinib treatment. The study of salivary gland cancer led to the discovery that the approved drug rapamycin may have great potential in the treatment of this cancer. A new method was developed to better study the cells that line and protect the prostate in relation to the development of cancer. Using this model, they found that normal cells and cancer cells depend on different factors to survive, which could aid in discovering how to target cancer cells without affecting normal cells when developing treatments. In collaboration with researchers at other organizations, a biomarker that could help in the treatment of patients with an aggressive type of lung cancer was discovered. Researchers identified an enzyme that could help diagnose and treat a form of liver cancer. A method was developed to predict whether pancreatic cysts are benign or are precursors to invasive cancer. Pancreatic cancer is often diagnosed in advanced stages beyond standard treatment options; detecting the cancer early could save many lives. Researchers also found that the protein PEBP1 could be a diagnositic marker for pancreatic cancer. | VARI's three largest program services by expenses |
| PART IV, LINE 32 | VARI NET ASSETS SHOULD BE CONSIDERED ON A CONSOLIDATED BASIS WITH VAN ANDEL INSTITUTE (VAI), VAN ANDEL EDUCATION INSTITUTE, AND THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, RELATED PARTIES. ON A CONSOLIDATED BASIS, NET ASSETS ARE $925,926,000 PER AUDITED FINANCIAL STATEMENTS. THE NEGATIVE NET ASSETS AT VARI ARE DUE TO VAI FUNDING EXPENSES ON A CASH BASIS. THEREFORE, ACCRUALS CAUSE NET ASSETS TO BE NEGATIVE. | |
| Form 990, Part VII, Section B | Compensation for Hunt - Owen Ames & Kimball excludes estimated materials and includes estimated labor on Hunt managed sub-contractors. | |
| form 990, part VII, Section A | Dr. Jeffrey Trent is not an independent voting member of the board for fiscal year ending November 30, 2010, because he was paid compensation. His compensation through VARI began in January 2010, and therefore, is not included in part VII, section A, column D. Compensation from the Translational Genomics Research Institute (TGEN), a related party beginning December 1, 2009, is included for the period December 1, 2009 through December 31, 2009. During this time period, Dr. Trent spent the majority of his time (51%) on VARI matters with the reminder of such time (approximately 49%) devoted to TGEN matters. | |
| form 990, part VII, Section B | JEFFREY BATTERSHALL IS LISTED AS SECRETARY ON PAGE 7. HE IS CONTRACTED THROUGH THE LAW FIRM WARNER, NORCROSS, & JUDD. ALL PAYMENTS FOR HIS SERVICES ARE PAID DIRECTLY TO WARNER, NORCROSS, & JUDD. | |
| FORM 990, PART IX, COLUMN D | FUNDRAISING EXPENSES AT VARI WERE INCURRED TO SUPPORT THE MISSION OF THE RESEARCH INSTITUTE THROUGH GRANT SOLICITATION AND EXTRAMURAL PROPOSAL PREPARATION. | |
| FORM 990, PART XI, LINE 2C | THE PROCESS FOR SELECTING THE AUDITOR FOR VAN ANDEL RESEARCH INSTITUTE'S FINANCIAL STATEMENTS DID NOT CHANGE DURING 2010. | |
| form 990, Schedule R, Part II | VARI became the sole member of the Translational Genomics Research Institute (TGen), an Arizona nonprofit, as of December 1, 2009. TGen has been recognized by the IRS as a tax-exempt corporation under section 501(c)(3) of the Code. THE primary mission of TGEN is to make and translate genomic discoveries into advances in human health. TGen has the following wholly owned entities that were created to support TGen through various functions: The Translational Genomics Research Institute Foundation (Foundation), TGen Accelerator Management, LLC, The Center for Translational Drug Development (TD2), and International Biosciences Commercialization Consortium, LLC (IBCC). |
Schedule R IRS990ScheduleR
Form990 Schedule R Part I Form990ScheduleRPartI (5 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Primary ActivitiesPrimaryActivities | Legal Domicile StateLegalDomicileState | Total IncomeTotalIncome | EOY AssetsEOYAssets | Direct Controlling Entity NADirectControllingEntityNA |
|---|---|---|---|---|---|---|---|---|---|
| VAI INNOVATIONS LLC | |||||||||
| 333 Bostwick Avenue NE | GRAND RAPIDS | MI | 49503 | 522000823 | Licensing Intellectual Property of VARI | MI | -762427 | 10974 | N/A |
| VARI International | |||||||||
| 333 Bostwick Avenue NE | GRAND RAPIDS | MI | 49503 | 262615936 | Biomedical research | MI | -47441 | 1268631 | N/A |
| XB TRANSMED SOLUTIONS LLC | |||||||||
| 333 Bostwick Avenue NE | GRAND RAPIDS | MI | 49503 | 203947727 | TRANSLATIONAL MEDICAL SOFTWARE AND SERVICES | MI | 181241 | N/A | |
| BOSTWICK EVENT MANAGEMENT | |||||||||
| 333 Bostwick Avenue NE | GRAND RAPIDS | MI | 49503 | 522000823 | EVENT MANAGEMENT | MI | -43636 | N/A | |
| paradise valley property llc | |||||||||
| 333 Bostwick Avenue NE | grAND RAPIDS | MI | 49503 | 522000823 | property transactions | MI | 0 | 0 | N/A |
Form990 Schedule R Part II Form990ScheduleRPartII (5 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Primary ActivitiesPrimaryActivities | Legal Domicile StateLegalDomicileState | Exempt Code SectionExemptCodeSection | Public Charity StatusPublicCharityStatus | Direct Controlling Entity NADirectControllingEntityNA | Business Name Line1DirectControllingEntityName/BusinessNameLine1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Van Andel Institute | ||||||||||
| 333 BOstwick Avenue NE | Grand Rapids | MI | 495032518 | 522000820 | Supporting organization for VARI and VAEI | MI | 501(c)(3) | 11c | N/A | |
| Van Andel Education Institute | ||||||||||
| 333 BOstwick Avenue NE | Grand Rapids | MI | 495032518 | 522000824 | Operating a School | MI | 501(c)(3) | 2 | N/A | |
| Van andel Institute Graduate School | ||||||||||
| 333 BOstwick Avenue NE | Grand Rapids | ME | 495032518 | 203340886 | Operating a School | MI | 501(c)(3) | 2 | Van Andel Education Institute | |
| THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE | ||||||||||
| 445 N 5TH STREET SUITE 600 | PHOENIX | AZ | 85004 | 753065445 | MEDICAL RESEARCH | AZ | 501(c)(3) | 7 | VAN ANDEL RESEARCH INSTITUTE | |
| TGEN RESEARCH INSTITUTE FOUNDATION | ||||||||||
| 400 E VAN BUREN SUITE 850 | PHOENIX | AZ | 85004 | 331092191 | FUNDRAISING | AZ | 501(c)(3) | 7 | N/A | |
Form990 Schedule R Part IV Form990ScheduleRPartIV
Name Of Related Org NameOfRelatedOrg
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TRANSMED SYSTEMS INC | BusinessNameLine1 |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 21170 CANYON OAK WAY | AddressLine1 |
| City | CUPERTINO | City |
| State | CA | State |
| ZIP Code | 95014 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 272358859 | EIN |
| Primary Activity | TRANSLATIONAL MEDICAL SOFTWARE AND SERVICES | PrimaryActivity |
| Legal Domicile State | CA | LegalDomicileState |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | VAN ANDEL RESEARCH INSTITUTE | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Type Of Entity | C | TypeOfEntity |
| Share Of Total Income | -410129 | ShareOfTotalIncome |
| Share Of EOY Assets | 178450 | ShareOfEOYAssets |
| Percentage Ownership | 0.55900 | PercentageOwnership |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Ann Rents Royalties | 1 | ReceiptOfIntAnnRentsRoyalties |
| Gift Grant Or Cap Contr To Other Org | 1 | GiftGrantOrCapContrToOtherOrg |
| Gift Grant Or Cap Contr Fr Other Org | 1 | GiftGrantOrCapContrFrOtherOrg |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrg |
| Loans Or Guarantees From Other Org | 1 | LoansOrGuaranteesFromOtherOrg |
| Sale Of Assets To Other Org | 0 | SaleOfAssetsToOtherOrg |
| Purchase Of Assets From Other Org | 0 | PurchaseOfAssetsFromOtherOrg |
| Exchange Of Assets | 0 | ExchangeOfAssets |
| Rental Of Facilities To Other Orgs | 0 | RentalOfFacilitiesToOtherOrgs |
| Rental Of Facilities Fr Other Orgs | 0 | RentalOfFacilitiesFrOtherOrgs |
| Perform Of Services For Other Orgs | 0 | PerformOfServicesForOtherOrgs |
| Perform Of Services By Other Orgs | 0 | PerformOfServicesByOtherOrgs |
| Sharing Of Facilities | 1 | SharingOfFacilities |
| Sharing Of Paid Employees | 1 | SharingOfPaidEmployees |
| Reimbursement Paid To Other Org | 1 | ReimbursementPaidToOtherOrg |
| Reimbursement Paid By Other Org | 1 | ReimbursementPaidByOtherOrg |
| Other Transfer To Other Org | 1 | OtherTransferToOtherOrg |
| Other Transfer From Other Org | 0 | OtherTransferFromOtherOrg |
Transactions Related Orgs Table TransactionsRelatedOrgsTable (12 entries)
| Transaction TypeTransactionType | Amount InvolvedAmountInvolved |
|---|---|
| Van Andel Institute | |
| C | 63319977 |
| Van Andel Institute | |
| E | 236690000 |
| Van Andel Institute | |
| O | 201052 |
| Van Andel Education Institute | |
| P | 1278596 |
| THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE | |
| Q | 10000000 |
| THE TRANSLATIONAL GENOMIC RESSEARCH INSTITUTE | |
| Q | 1078497 |
| THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE | |
| N | 340951 |
| THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE | |
| C | 1234367 |
| THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE | |
| K | 42680 |
| van andel institute graduate school | |
| B | 8022 |
| TRANSMED SYSTEMS INC | |
| A | 100000 |
| TRANSMED SYSTEMS INC | |
| B | 500000 |
Comments